diabetestalk.net

Saturated Fats, Diabetes And Carb/Sugar Consumption

Saturated Fats, Diabetes and Carb/Sugar Consumption

Saturated Fats, Diabetes and Carb/Sugar Consumption

I received this detailed response to a recent video on my YouTube Channel about the documentary, What The Health. My response follows as a helpful guide, just in case you face a similar crisis with a friend or loved one down the road too. The YouTube video in question in this case is also at the bottom of the post if you’d like to watch it.
The Argument
TheAltruismActivist: Hello Paul. Addressing your concern about the recommendations and research on diabetes, I believe that you are not looking deep enough into the issue.
Just because eating a sugary meal raises one’s blood sugar does not mean that sugar is the cause and main culprit of diabetes. Looking into it a step deeper, you must consider why the body is insulin-resistant (which causes the high, uncontrolled blood sugar).
There is much proof that dietary saturated fat is a significant inducer of insulin resistance. Pouring sugar into an insulin-resistant person’s body will surely exacerbate the diabetic issues, but the sugar intake is not the cause. Dietary saturated fat is.
That is how Dr. Walter Kempner, many decades ago, cured type 2 diabetics with a diet composed of white rice, white sugar, fruit, and fruit juice. That is not a healthy diet, but it proves that sugar is not the issue while dietary saturated fat is.
Switching anyone from a standard Western diet to a cleaner diet like yours will improve their diabetes, but that doesn’t mean further benefits can’t be obtained from digging deeper into the root cause of insulin resistance. Let me know your thoughts and response!
Study various diets
Hello! Afte Continue reading

Rate this article
Total 1 ratings
The Hidden Culprit behind Diabetes

The Hidden Culprit behind Diabetes

“Refined sugar” is a phrase that strikes fear in our hearts. As consumers, we’re all too familiar with America’s war on sugar. Deemed a “silent killer,” sugar is identified as a major cause of obesity, heart disease, and diabetes. The past decade has seen a cascade of sugar substitutes, including Splenda and a slew of other trendy packets that cheerfully promise “sugar free.” Is this really the entire story, though? For diabetics, and for those of us who want to maintain our health, there is yet another line on the nutrition label that is far too often overlooked.
Most people in America are aware of the dangers of type II diabetes. After all, almost one in every ten people in the country is diabetic. One in every five health care dollars is spent caring for people with diabetes. There’s no question about it — this disease is a national problem.
Type II diabetes is characterized by the body’s impaired ability to respond to insulin and subsequently metabolize sugar, or glucose. Ideally, whenever we eat, our bodies break food down into glucose, which is absorbed into the blood and taken up by muscle cells to be stored or burned for energy. There’s a catch, though. Glucose in the blood needs a key to get into our cells, and that key is insulin. Cells in the pancreas, called beta cells, are responsible for the secretion of insulin that regulates our blood sugar levels.
When blood sugar levels are always elevated from eating refined sugar, over time, the body stops responding to insulin — a condition called insulin resistance. Insulin resistance is the s Continue reading

Xultophy® Reported a Better Option than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Participants in the DUAL VII Clinical Trial

Xultophy® Reported a Better Option than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Participants in the DUAL VII Clinical Trial

Abu Dhabi, Uae (ots/PRNewswire) - Once-daily Xultophy® (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). This was reported by people with type 2 diabetes whose blood sugar was not controlled on insulin glargine U100 with metformin, and who completed quality-of-life questionnaires as part of the DUAL VII clinical trial.[1] In addition, more people preferred to stay on Xultophy® compared with basal-bolus therapy (84.5% versus 68.1%).[1] These results were presented today at the 2017 International Diabetes Federation Congress in Abu Dhabi, UAE.
"Adding insulin injections at mealtime is an effective option to achieve desired blood glucose levels when basal insulin is not enough, but this raises the level of complexity in the patients' daily management of their diabetes. It can also lead to an increased risk of hypoglycaemia (low blood sugar) or weight gain", said Professor Esteban Jódar, University Hospital Quirón Salud, Madrid, Spain. "In the main analysis of the DUAL VII trial, Xultophy® delivered similar glucose reductions to a basal-bolus regimen alongside weight loss, as opposed to weight gain, and fewer episodes of hypoglycaemia. We now see that it also reduces treatment burden."
In the patient-reported outcomes (PRO) analysis from the DUAL VII clinical trial, 506 adults living with type 2 diabetes assessed their physical health, mental health and a number of diabetes-specific factors. These scores were measured using the validated Treatment-Related Impact Measure-Diabetes (TR Continue reading

15 Tips on Diabetic Dog Food and How to Feed Dogs with Diabetes

15 Tips on Diabetic Dog Food and How to Feed Dogs with Diabetes

Having a dog diagnosed with diabetes can be daunting. Fortunately, however, canine nutrition has come a long way in recent years. We now have a much better understanding of canine diabetes and the part that proper nutrition can play in it. Diabetic dog food can help you regulate your pet’s condition without a lot of medications.
Although a canine diabetes diagnosis can be scary, know that it is not the end of the world. Canine diabetes can be easily and effectively managed so long as you have the right tools and the plenty of knowledge on your side.
For this reason, it’s imperative that you work with your veterinarian, a canine nutritionist and any other member of your pet health team. Planning the right treatment for a diabetic dog is not something that you can do on your own.
Your veterinarian will be able to guide you in selecting the treatment plan that will meet your dog’s needs and your budget. This plan may include diabetic dog food, medication and a change in activity level. While it will require more effort on your part, caring for a diabetic dog is not as difficult as you may originally think.
ALSO READ: Dog Food for Dogs with Diabetes – What You Need to Know
15 Tips on Diabetic Dog Food
and how to feed dogs with diabetes
1. Talk to your vet about your diabetic dog’s diet
When your dog is first diagnosed with diabetes, the first thing you should do is talk to your vet about your dog’s diet. Depending on your dog’s current state of health, you may or may not need to make adjustments to the quantity or type of food that your dog eats.
Not all dogs with Continue reading

New measure of insulin-making cells could gauge diabetes progression, treatment

New measure of insulin-making cells could gauge diabetes progression, treatment

Researchers at the University of Wisconsin–Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.
In a study published in the August edition of the journal Diabetes, Weibo Cai, Matthew J. Merrins and colleagues used a PET scanner to detect minute levels of a radioactive chemical in the mouse pancreas. Cai, the senior author of the study and an associate professor of radiology, says that unlike previous methods for measuring the quantity of beta cells, the new test also measures how actively these cells are making insulin.
PET scanning, or positron emission tomography, is used to detect minute quantities of tracers, commonly for finding cancer and metastases. This area is a specialty of Cai. Cai says the test may be used to evaluate treatments or cell transplants intended to slow or reverse diabetes.
With a provisional patent filed through the Wisconsin Alumni Research Foundation, Cai has begun planning a series of human trials that could lead to Food and Drug Administration clearance for a new method to determine the quantity and condition of the beta cells. The first step in these trials would look at the distribution and potential toxicity of the radioactive manganese chloride used as a tracer.
A shortage of insulin, due to the death or inactivity of the beta cells, causes type I (formerly “juvenile“) diabetes. The same problem can also cause type II diabetes. But this condition, once called “adult onset” diabetes, can also result from insufficient response to insulin. “In some co Continue reading

No more pages to load

Popular Articles

--}} {{--

Related Articles